blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2286796

EP2286796 - Controlled release formulation comprising albuterol [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.10.2014
Database last updated on 24.04.2024
Most recent event   Tooltip17.10.2014Application deemed to be withdrawnpublished on 19.11.2014  [2014/47]
Applicant(s)For all designated states
Penwest Pharmaceuticals Co.
2981 Route 22
Patterson, NY 12563-9970 / US
[2011/08]
Inventor(s)01 / Baichwal, Anand R.
5 Kendell Drive
Wappinger Falls, NY 12590 / US
02 / McCall, Troy W.
4 Sullivan Farm
New Milford, CT 06776 / US
 [2011/08]
Representative(s)Stephen, Robert John
CMS Cameron McKenna Nabarro
Olswang LLP
Cannon Place
78 Cannon Street
London EC4N 6AF / GB
[N/P]
Former [2011/08]Stephen, Robert John
Olswang 90 High Holborn
GB-London WC1V 6XX / GB
Application number, filing date10178632.504.11.1996
[2011/08]
Priority number, dateUS1995055300803.11.1995         Original published format: US 553008
[2011/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2286796
Date:23.02.2011
Language:EN
[2011/08]
Type: A3 Search report 
No.:EP2286796
Date:22.02.2012
Language:EN
[2012/08]
Search report(s)(Supplementary) European search report - dispatched on:EP23.01.2012
ClassificationIPC:A61K9/14, A61K9/22, A61K31/137, A61P11/08
[2011/08]
CPC:
A61K31/137 (EP,US); A61K9/20 (KR); A61K9/2009 (EP,US);
A61K9/2018 (EP,US); A61K9/205 (EP,US); A61K9/2054 (EP,US);
A61K9/2866 (EP,US); A61P11/08 (EP); C08J3/075 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2011/08]
TitleGerman:Formulierungen mit kontrollierter Abgabe von Albuterol[2011/08]
English:Controlled release formulation comprising albuterol[2011/08]
French:Formulation à libération contrôlée d'albuterol[2012/09]
Former [2011/08]Formulation a libération contrôlée d'albuterol
Examination procedure22.08.2012Amendment by applicant (claims and/or description)
22.08.2012Examination requested  [2012/40]
14.09.2012Despatch of a communication from the examining division (Time limit: M04)
24.01.2013Reply to a communication from the examining division
03.06.2014Application deemed to be withdrawn, date of legal effect  [2014/47]
02.07.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/47]
Parent application(s)   TooltipEP96940352.6  / EP0804166
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19960940352) is  14.09.2007
Fees paidRenewal fee
23.09.2010Renewal fee patent year 03
23.09.2010Renewal fee patent year 04
23.09.2010Renewal fee patent year 05
23.09.2010Renewal fee patent year 06
23.09.2010Renewal fee patent year 07
23.09.2010Renewal fee patent year 08
23.09.2010Renewal fee patent year 09
23.09.2010Renewal fee patent year 10
23.09.2010Renewal fee patent year 11
23.09.2010Renewal fee patent year 12
23.09.2010Renewal fee patent year 13
23.09.2010Renewal fee patent year 14
24.11.2010Renewal fee patent year 15
23.11.2011Renewal fee patent year 16
07.11.2012Renewal fee patent year 17
Penalty fee
Additional fee for renewal fee
30.11.201318   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]US4309405  (GULEY PAUL C, et al) [X] 1,3,5,7,8,15 * example 1 * * claim - * [I] 2,4,6,9-14;
 [I]EP0360562  (MENDELL CO INC EDWARD [US]) [I] 1-15 * claims 1-15,20-22 * * page 7; examples 1-15 ** page 9; examples 25,26; table 5 *;
 [I]EP0539059  (SQUIBB & SONS INC [US]) [I] 1-15 * claims 1,11,13,14 * * page 3, line 31 - line 56 * * example 1 *;
 [X]EP0642785  (MENDELL CO INC EDWARD [US]) [X] 1-15 * page 13; example 15 *
by applicantUS4839177
 US4994276
 EP0234670
 US5128143
 US5135757
    - Kirk-Othmer Encyclopedia of Chemical Technology, vol. 5, pages 857 - 884
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.